Treatment cost and life expectancy of diffuse large B-cell lymphoma (DLBCL): a discrete event simulation model on a UK population-based observational cohort

BACKGROUND: Diffuse large B-cell lymphoma (DLBCL) is the commonest non-Hodgkin lymphoma. Previous studies examining the cost of treating DLBCL have generally focused on a specific first-line therapy alone; meaning that their findings can neither be extrapolated to the general patient population nor...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Han-I., Smith, Alexandra, Aas, Eline, Roman, Eve, Crouch, Simon, Burton, Cathy, Patmore, Russell
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5313581/
https://www.ncbi.nlm.nih.gov/pubmed/26969332
http://dx.doi.org/10.1007/s10198-016-0775-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5313581/
https://www.ncbi.nlm.nih.gov/pubmed/26969332
http://dx.doi.org/10.1007/s10198-016-0775-4

Ejemplares similares